Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AML08: Clofarabine + Cytarabine vs ADE in Pediatric AML
NCT00703820Phase 3Completed
- Sponsor
- St. Jude Children's Research Hospital
- Start
- Aug 2008
- Primary completion
- Mar 2017
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 2
01
Overview
Phase 3, randomised, open-label trial of clofarabine in acute myeloid leukemia (AML), sponsored by St. Jude Children's Research Hospital. Primary endpoint: Minimal Residual Disease at Day 22. Started Aug 2008; status: completed.
02
Drugs
clofarabine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT00703820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00703820.